Cure My Disease

Don't miss your cure!

 Log in / Sign up

Stress-Busting program tested for triple negative breast cancer

NCT ID NCT05677802

Recruiting now Symptom relief Sponsor: Ohio State University Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 30, 2026 · Updated 3 times

Summary

This study tests whether a 10-week stress reduction program is doable and helpful for people with triple negative breast cancer. The program includes relaxation, coping skills, and social support, and also addresses basic needs like utilities or transportation. Researchers will measure stress levels and biological markers in 40 participants to see if the program improves well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Stress management therapy (biobehavioral stress reduction program)
What this could lead to
If successful, this could show that a stress reduction program helps triple negative breast cancer patients feel better and cope with treatment.
What could go wrong
This is a small, early feasibility study with only 40 participants, so results may not apply to everyone. It focuses on stress, not on treating the cancer itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE I BREAST CANCER AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer estrogen-receptor negative breast cancer Her2-receptor negative breast cancer triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANATOMIC STAGE I BREAST CANCER AJCC V8 ANATOMIC STAGE II BREAST CANCER AJCC V8 ANATOMIC STAGE III BREAST CANCER AJCC V8 HER2-NEGATIVE BREAST CARCINOMA HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA TRIPLE-NEGATIVE BREAST CARCINOMA

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • MetroHealth

    RECRUITING

    Cleveland, Ohio, 44109, United States

  • Ohio State University Comprehensive Cancer Center

    RECRUITING

    Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.